Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: To date, the molecular function of most of the reported type 2 diabetes-associated loci remains unknown. The introduction or removal of cytosine-phosphate-guanine (CpG) dinucleotides, which are possible sites of DNA methylation, has been suggested as a potential mechanism through which single-nucleotide polymorphisms (SNPs) can affect gene function via epigenetics. The aim of this study was to examine if any of 40 SNPs previously associated with type 2 diabetes introduce or remove a CpG site and if these CpG-SNPs are associated with differential DNA methylation in pancreatic islets of 84 human donors. METHODS: DNA methylation was analysed using pyrosequencing. RESULTS: We found that 19 of 40 (48%) type 2 diabetes-associated SNPs introduce or remove a CpG site. Successful DNA methylation data were generated for 16 of these 19 CpG-SNP loci, representing the candidate genes TCF7L2, KCNQ1, PPARG, HHEX, CDKN2A, SLC30A8, DUSP9, CDKAL1, ADCY5, SRR, WFS1, IRS1, DUSP8, HMGA2, TSPAN8 and CHCHD9. All analysed CpG-SNPs were associated with differential DNA methylation of the CpG-SNP site in human islets. Moreover, six CpG-SNPs, representing TCF7L2, KCNQ1, CDKN2A, ADCY5, WFS1 and HMGA2, were also associated with DNA methylation of surrounding CpG sites. Some of the type 2 diabetes CpG-SNP sites that exhibit differential DNA methylation were further associated with gene expression, alternative splicing events determined by splice index, and hormone secretion in the human islets. The 19 type 2 diabetes-associated CpG-SNPs are in strong linkage disequilibrium (r² > 0.8) with a total of 295 SNPs, including 91 CpG-SNPs. CONCLUSIONS/INTERPRETATION: Our results suggest that the introduction or removal of a CpG site may be a molecular mechanism through which some of the type 2 diabetes SNPs affect gene function via differential DNA methylation and consequently contributes to the phenotype of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These CpG-SNPs are associated with differential DNA methylation, gene expression, alternative splicing events, and hormone secretion in human pancreatic islets, suggesting strong genetic-epigenetic interactions ( 26 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
CpG islands and the regulation of transcription
Deaton, A. M., & Bird, A. (2011) · Genes & Development · doi:10.1101/gad.2037511 · Cited by 3,187
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843 · cited 1×
“developing type 2 diabetes [21, 24, 43–45].”
Self-citationA genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · cited 1×
“SNPs within TCF7L2 confer the highest genetic risk of developing type 2 diabetes [21, 24, 43 – 45].”
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
DIAGRAM Consortium, Dupuis, J., GIANT Consortium, Global BPgen Consortium, Anders Hamsten on behalf of Procardis Consortium, the MAGIC investigators, Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., et al. (2010) · Nature Genetics · doi:10.1038/ng.520 · Cited by 2,166
Wellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Self-citationTwelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Conserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743 · cited 1×
“Intragenic DNA methylation has also been suggested to play a direct role in reducing or enhancing transcription elongation efficiency via alternative promoters located within gene bodies [40] or indirectly by regulating non-coding transcripts that then affect the transcription of the associated genes [41, 42].”
Matrix eQTL: ultra fast eQTL analysis via large matrix operations
Shabalin, A. A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts163 · Cited by 1,694
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
Johnson, A. D., Handsaker, R. E., Pulit, S. L., Nizzari, M. M., O'Donnell, C. J., & de Bakker, P. I. W. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn564 · Cited by 1,330
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing
Shukla, S., Kavak, E., Gregory, M., Imashimizu, M., Shutinoski, B., Kashlev, M., Oberdoerffer, P., Sandberg, R., & Oberdoerffer, S. (2011) · Nature · doi:10.1038/nature10442 · Cited by 973 · cited 2×
“Associations between type 2 diabetes CpG-SNPs that exhibit differential DNA methylation and alternative splicing events in human islets There are further data supporting a role for DNA methylation in alternative splicing events [31].”
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation
Jia, D., Jurkowska, R. Z., Zhang, X., Jeltsch, A., & Cheng, X. (2007) · Nature · doi:10.1038/nature06146 · Cited by 846
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., Hirota, Y., Mori, H., Jonsson, A., Sato, Y., et al. (2008) · Nature Genetics · doi:10.1038/ng.207 · Cited by 776 · cited 1×
“CpG-SNPs where risk alleles introduce a CpG site (n=11) rs13292136 CHCHD9 C 9 81952128 Intergenic Voight et al (2010) [20] rs7901695 TCF7L2 G 10 114754088 Intron Zeggini et al (2007) [21] rs7754840 CDKAL1 C 6 20661250 Intron Scott et al (2007) [24] rs391300 SRR G 17 2216258 Intron Tsai et al (2010) [25] rs5015480 HHEX…”
Epigenetics: a molecular link between environmental factors and type 2 diabetes
Ling, C., & Groop, L. (2009) · Diabetes · doi:10.2337/db09-1003 · Cited by 617 · cited 1×
“Type 2 diabetes is a heterogeneous disease caused by a complex interplay between multiple genetic, epigenetic and environmental factors [1].”
Self-citationParental origin of sequence variants associated with complex diseases
DIAGRAM Consortium, Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher, S., Jonasdottir, A., Sigurdsson, A., Kristinsson, K. T., et al. (2009) · Nature · doi:10.1038/nature08625 · Cited by 553 · cited 1×
“CpG-SNPs where risk alleles remove a CpG site (n=8) rs5945326 DUSP9 A X 152899922 Intergenic Voight et al (2010) [20] rs564398 CDKN2A A 9 22029547 Intergenic Zeggini et al (2007) [21] rs11708067 ADCY5 A 3 123065778 Intron Dupuis et al (2010) [22] rs1801214 WFS1 T 4 6303022 Cds-synon Voight et al (2010) [20] rs2334499…”
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
Ling, C., Del Guerra, S., Lupi, R., Rönn, T., Granhall, C., Luthman, H., Masiello, P., Marchetti, P., Groop, L., & Del Prato, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0916-5 · Cited by 495 · cited 1×
“Recent studies from our group and others have shown that epigenetic modifications such as DNA methylation and histone modifications may affect the pathogenesis of type 2 diabetes [4 – 9].”
Self-citationMatrix eQTL: Ultra fast eQTL analysis via large matrix operations
Shabalin, A. A. (2011) · arXiv (Cornell University) · doi:10.17615/g28n-r219 · Cited by 452
Volkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo‐Esteve, M., Naamane, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.503 · Cited by 420 · cited 1×
“Recent studies from our group and others have shown that epigenetic modifications such as DNA methylation and histone modifications may affect the pathogenesis of type 2 diabetes [4–9].”
Nitert, M. D., Dayeh, T., Volkov, P., Elgzyri, T., Hall, E., Nilsson, E., Yang, B. T., Lang, S., Parikh, H., Wessman, Y., et al. (2012) · Diabetes · doi:10.2337/db11-1653 · Cited by 403
Self-citationCooper, D., & Krawczak, M. (1990) · Human Genetics · doi:10.1007/bf00276326 · Cited by 387
Tsai, F.-J., Yang, C.-F., Chen, C.-C., Chuang, L.-M., Lu, C.-H., Chang, C.-T., Wang, T.-Y., Chen, R.-H., Shiu, C.-F., Liu, Y.-M., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000847 · Cited by 346
Molecular studies of major depressive disorder: the epigenetic perspective
Mill, J., & Petronis, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001992 · Cited by 302
Yang, B. T., Dayeh, T. A., Volkov, P. A., Kirkpatrick, C. L., Malmgren, S., Jing, X., Renström, E., Wollheim, C. B., Nitert, M. D., & Ling, C. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1004 · Cited by 301 · cited 2×
“Islet culture and nucleic acid purification were performed as described previously [7].”
Self-citationGertz, J., Varley, K. E., Reddy, T. E., Bowling, K. M., Pauli, F., Parker, S. L., Kucera, K. S., Willard, H. F., & Myers, R. M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002228 · Cited by 300
Cell type–specific DNA methylation at intragenic CpG islands in the immune system
Deaton, A. M., Webb, S., Kerr, A. R. W., Illingworth, R. S., Guy, J., Andrews, R., & Bird, A. (2011) · Genome Research · doi:10.1101/gr.118703.110 · Cited by 284
Tong, Y., Lin, Y., Zhang, Y., Yang, J., Zhang, Y., Liu, H., & Zhang, B. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-15 · Cited by 262
Yang, B. T., Dayeh, T. A., Kirkpatrick, C. L., Taneera, J., Kumar, R., Groop, L., Wollheim, C. B., Nitert, M. D., & Ling, C. (2011) · Diabetologia · doi:10.1007/s00125-010-1967-6 · Cited by 251
Self-citationReduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes
Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., et al. (2012) · Diabetes · doi:10.2337/db11-1516 · Cited by 237
Self-citationGenetic variants at 2q24 are associated with susceptibility to type 2 diabetes
Qi, L., Cornelis, M. C., Kraft, P., Stanya, K. J., Linda Kao, W. H., Pankow, J. S., Dupuis, J., Florez, J. C., Fox, C. S., Paré, G., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq156 · Cited by 191
Ling, C., Poulsen, P., Simonsson, S., Rönn, T., Holmkvist, J., Almgren, P., Hagert, P., Nilsson, E., Mabey, A. G., Nilsson, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30938 · Cited by 189
Self-citationAge influences DNA methylation and gene expression of COX7A1 in human skeletal muscle.
Rönn, T., Poulsen, P., Hansson, O., Holmkvist, J., Almgren, P., Nilsson, P., Tuomi, T., Isomaa, B., Groop, L., Vaag, A., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1018-8 · Cited by 175 · cited 1×
“Recent studies from our group and others have shown that epigenetic modifications such as DNA methylation and histone modifications may affect the pathogenesis of type 2 diabetes [4–9].”
Self-citationTaqi, M. M., Bazov, I., Watanabe, H., Sheedy, D. L., Harper, C. G., Alkass, K., Druid, H., Wentzel, P., Nyberg, F., Yakovleva, T., et al. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00323.x · Cited by 139
Wen, J., Rönn, T., Olsson, A., Yang, Z., Lu, B., Du, Y., Groop, L., Ling, C., & Hu, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009153 · Cited by 127
Self-citationRuchat, S.-M., Elks, C. E., Loos, R. J. F., Vohl, M., Weisnagel, S. J., Rankinen, T., Bouchard, C., & Përusse, L. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0080-5 · Cited by 116
Olsson, A. H., Yang, B. T., Hall, E., Taneera, J., Salehi, A., Dekker Nitert, M., & Ling, C. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0282 · Cited by 80
Self-citationUnique splicing pattern of the TCF7L2 gene in human pancreatic islets
Osmark, P., Hansson, O., Jonsson, A. E., Rönn, T., Groop, L., & Renström, E. (2009) · Diabetologia · doi:10.1007/s00125-009-1293-z · Cited by 72
Self-citationSigurdsson, M. I., Smith, A. V., Bjornsson, H. T., & Jónsson, J. J. (2009) · Genome Research · doi:10.1101/gr.086181.108 · Cited by 71
The Dinucleotide CG as a Genomic Signalling Module
Bird, A. P. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.056 · Cited by 61
Solomon, T. P. J., Knudsen, S. H., Karstoft, K., Winding, K., Holst, J. J., & Pedersen, B. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2097 · Cited by 51
A candidate CpG SNP approach identifies a breast cancer associated ESR1‐SNP
Harlid, S., Ivarsson, M. I. L., Butt, S. T., Hussain, S. K., Grzybowska, E. A., Eyfjord, J. E., Lenner, P., Försti, A., Hemminki, K., Manjer, J., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25786 · Cited by 39
Ståhle, M., Brandhorst, D., Korsgren, O., & Knutson, F. (2010) · Cell Transplantation · doi:10.3727/096368910x539056 · Cited by 23
Nemr, R., Turki, A., Echtay, A. S., Al-Zaben, G. S., Daher, H. S., Irani-Hakime, N. A., Keleshian, S. H., & Almawi, W. Y. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.044 · Cited by 22
Gene Array Analyzer: alternative usage of gene arrays to study alternative splicing events
Gellert, P., Teranishi, M., Jenniches, K., Gaspari, P. D., John, D., Kreymborg, K. G., Braun, T. W., & Uchida, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1110 · Cited by 17
Cited by
Epigenetics in Human Obesity and Type 2 Diabetes
Ling, C., & Rönn, T. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.009 · Cited by 941
Self-citationRönn, T., Volkov, P., Davegårdh, C., Dayeh, T., Hall, E., Olsson, A. H., Nilsson, E., Tornberg, Å., Dekker Nitert, M., Eriksson, K.-F., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003572 · Cited by 618
“supported by multiple studies showing a positive correlation between gene body methylation and active transcription [40], and that DNA methylation may regulate exon splicing [41,42].”
Self-citationLawlor, N., George, J., Bolisetty, M., Kursawe, R., Sun, L., Sivakamasundari, V., Kycia, I., Robson, P., & Stitzel, M. L. (2017) · Genome Research · doi:10.1101/gr.212720.116 · Cited by 562
“We also investigated cell type expression patterns of 536 islet expression quantitative trait loci (eQTL) target genes (Lyssenko et al. 2009; Dupuis et al. 2010; Dayeh et al. 2013; Fadista et al. 2014; Kulzer et al. 2014; van de Bunt et al. 2015).”
Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004160 · Cited by 523
“delete possible DNA methylations sites [27].”
InfluentialSelf-citationEpigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
Metadata
- Authors
- Dayeh, T. A., Olsson, A. H., Volkov, P., Almgren, P., Rönn, T., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, C.
- Venue
- Diabetologia
- Published
- 2013-03-06
- Volume
- 56
- Issue
- 5
- Pages
- 1036-1046
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC3622750
- OpenAlex
- W2144460023
- Cited by
- 199
- References
- 50
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 12 · 2023: 8 · 2022: 13 · 2021: 6 · 2020: 15 · 2019: 18 · 2018: 14 · 2017: 16 · 2016: 21 · 2015: 31 · 2014: 23 · 2013: 9
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetologia (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, DNA methylation, pancreatic islets, epigenetics, TCF7L2, KCNQ1, CDKN2A, HMGA2, WFS1, ADCY5, linkage disequilibrium, gene expression, alternative splicing, insulin secretion, islet hormone secretion
- MeSH terms
- Insulin Secretion, Aged, Diabetes Mellitus, Type 2, Female, Gene Expression Regulation, Humans, Insulin, Islets of Langerhans, Male, Middle Aged, RNA, Messenger, Scandinavian and Nordic Countries, Tissue Donors, Cohort Studies, Linkage Disequilibrium, Alternative Splicing, CpG Islands, DNA Methylation, Polymorphism, Single Nucleotide, Epigenesis, Genetic, Tissue Culture Techniques, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.